The latest setback in the race for a coronavirus vaccine

Welcome to Business Insiders daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.



Hollis Johnson/Business Insider


© Hollis Johnson/Business Insider
Hollis Johnson/Business Insider

Hello,

On Monday evening, Johnson & Johnson said it halted all dosing associated with its coronavirus vaccine trials after an “unexplained illness” in a participant, as first reported by Stat News. It’s another setback to the vaccine race after AstraZeneca’s trial also hit a snag in September. 

We’re officially three weeks away from the presidential election. Between that and arguments slated for next month on the Affordable Care Act, all eyes are on the Trump administration to have a plan should the law be struck down.

Kimberly Leonard spoke to one of Trump’s top advisors about what might happen, since the administration hasn’t laid out a plan to replace the law.

And across the pond, England is getting set to start closing parts of the country down as case counts rise.

Elsewhere in healthcare news: Pfizer’s expanding its vaccine trial to include kids as young as 12, what antiabortion groups think of Trump taking an experimental drug tested on cells derived from an aborted fetus, and antibody drug trials have seen an uptick in interest. 



a woman in a blue shirt: Steve Parsons-WPA Pool/Getty Images


© Steve Parsons-WPA Pool/Getty Images
Steve Parsons-WPA Pool/Getty Images

Pfizer will start testing its coronavirus vaccine on children as young as 12, a crucial step to bringing the shot to more people

Read the full story from Andrew Dunn here>>



Donald Trump wearing a suit and tie: President Donald Trump stands on the balcony outside of the Blue Room as returns to the White House Monday, Oct. 5, 2020, in Washington. Alex Brandon/AP


© Alex Brandon/AP
President Donald Trump stands on the balcony outside of the Blue Room as returns to the White House Monday, Oct. 5, 2020, in Washington. Alex Brandon/AP

Antiabortion groups say they stand behind Trump’s use of a drug tested on cells derived from an aborted fetus because the president ‘was not involved with that abortion’

  • An antibody cocktail President Trump received for his COVID-19 treatment was tested using stem cells derived from a fetus that was aborted in 1972 in the Netherlands.
  • Antiabortion organizations have spoken out against the use of these stem cells, which have been lab-engineered and duplicated, to test vaccines. Trump has also restricted use of these stem cells in research.
  • Three leaders of antiabortion organizations told Insider that though the testing wasn’t ethical, they stood behind Trump’s decision.
  • One said Trump has been “sensational on the life issues.”

Read the full story from Julia Naftulin here>>



a person wearing glasses: FILE PHOTO: Scientists work in a lab testing COVID-19 samples at New York City's health department, during the outbreak of the coronavirus disease (COVID-19) in New York Reuters


© Reuters
FILE PHOTO: Scientists work in a lab testing COVID-19 samples at New York City’s health department, during the outbreak of the coronavirus disease (COVID-19) in New York Reuters

More patients want to join antibody drug trials after Trump’s coronavirus treatment — though we don’t know yet if it actually helps COVID-19

Read the full story from Sinéad Baker here>>

More stories we’re reading:

Subscribe to our newsletter here.

– Lydia 

Continue Reading

Source Article